This article was originally published in The Tan Sheet
The public can comment on "possible additional directions" the Office of Dietary Supplements should consider in its five-year strategic plan during a May 20 public meeting, the NIH office announces in a Federal Register notice. The revised version of the five-year plan, which guides ODS activities from 2004 to 2009, was released in January and includes program goals such as expanding the evaluation of the role supplements play in disease prevention....
You may also be interested in...
The first data readout for remdesivir, the much anticipated antiviral for the coronavirus pandemic, is expected in days. Scrip surveys antiviral development and regulatory experts to gauge their interest and the key aspects to watch for in the milestone announcement.
The UK has an “excellent but small diagnostics industry,” so it needs further testing support from related life science industries to tackle the COVID-19 crisis. One of the outcomes of this could be the creation of new big diagnostics industry players.